CardieX Ltd. engages in the provision of designing, manufacturing, and marketing medical devices used in cardiovascular health management. It operates through the following geographical segments: Americas, Europe, and Asia Pacific. The Americas segment includes pharmaceutical trials business. The Europe segment focuses on the Middle East and Africa. The Asia Pacific segment is involved in the operations of Asia, Australia, and New Zealand. The company was founded by Ross Harricks, Niall Charles Edgar Cairns, Craig R. Cooper, and Michael Francis O'Rourke in 1994 and is headquartered in Sydney, Australia.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company